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H
yperglycemia, hypoglycemia, and
glucose variability are common
during intensive care unit (ICU)
stay and are associated with increased
mortality (1–3). Continuous glucose
monitoring (CGM) is a promising tool to
assist glucose control, but the accuracy
and reliabilityofthese devices in critically
ill patients is uncertain (4,5). Therefore,
we studied two different CGM devices
postoperatively in cardiac surgery pa-
tients in an investigator-initiated trial.
We placed two CGM devices (Guard-
ian RT, Medtronic Minimed; FreeStyle
Navigator, Abbott Diabetes Care) sub-
cutaneously in the abdominal wall before
surgery in 60 patients. This is the ﬁrst
time the Navigator has been studied in an
ICU setting. Both devices were calibrated
simultaneously upon arrival at the ICU
after surgery. Further calibrations were
performedaccordingtomanufacturers’in-
structions. An arterial blood glucose value
was measured with an AccuChek device
(Performa II, Roche/Hitachi) as a reference
value every 2 hours. Relative absolute de-
viation (RAD) between reference and sen-
sor glucose values was calculated in six
5-min intervals after the time of the refer-
ence glucose to assess a possible delay.
Ofthe60patients,48weremalewitha
median (range) age of 65 years (25–85),
and 16 were diagnosed with type 2 diabe-
tes. The median (IQR) maximum Sequen-
tial Organ Failure Assessment score and
ICU stay were 6.0 (5.3–7.0) and 23.0
hours(19.0–45.8),andmean(SD)glucose
was 8.2 (2.1) mmol/L. We obtained 1,017
reference glucose values of which 77.8%
c o u l db ep a i r e dw i t haG u a r d i a na n d
91.8% with a Navigator value in the ﬁrst
interval. Missing values indicate technical
problems with the device: signal loss
(Guardian: 19 patients; Navigator: 1 pa-
tient), sensor failure (Guardian: 7 patients;
Navigator:2patients),interruptionofreal-
time representation of glucose values after
delayed recalibration (Guardian) or tem-
porarily failure of data-recording (Naviga-
tor: 4 patients).
Median (IQR) RAD was signiﬁcantly
smaller for Navigator compared with
Guardian glucose measurements at inter-
vals 0–4a n d5 –9 min after the reference
glucose (11% [8–16] and 10% [8–16]
compared with 14% [11–18] and 14%
[11–17], P 5 0.05 and P 5 0.001,
Wilcoxon signed rank test). The lowest
RAD of the Navigator was observed 5–
9 min after reference glucose, but no sig-
niﬁcant effect of time was seen (P 5 0.74,
repeated measures ANOVA). The accu-
racy of the Guardian did show a delay
with the lowest RAD after 15–19 min
(11% [8–13], P 5 0.01). There was no
consistency in under- or overestimation
of the reference glucose values. No sepa-
rate analyses to assess accuracy during hy-
poglycemia were performed because no
severe hypoglycemia (#2.2 mmol/L) was
measured and only 34 of 1,017 reference
glucose values were mildly hypoglycemic
(#4.7 mmol/L) (1).
We report that the FreeStyle Naviga-
tor CGM system performed better than
the Guardian RT in accuracy as well as
reliabilityinpostoperativecardiacsurgery
patients during ICU stay. Remarkably,
the RAD of both sensors was quite good
compared with reported data for out-
patients. According to these results, we
conclude that this device can be used in
this group of ICU patients characterized
by relatively low disease severity scores
and low mortality rates. Whether or
not the use of CGM improves glycemic
control and mortality needs further
research.
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